Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series
Alexander Wong(University of British Columbia), Brittany B. Dennis(University of British Columbia), Piper Dickhout(British Columbia Centre on Substance Use), Addie Carter(Providence Health Care), Renée M. Janssen(University of British Columbia), Paxton Bach(University of British Columbia), Bohdan Nosyk(Simon Fraser University), Clete Johnson(University of British Columbia Hospital), Rhea Beauchesne(British Columbia Centre on Substance Use), Seonaid Nolan(University of British Columbia), Felicia Yang(University of British Columbia), Travis Wolfe(British Columbia Centre on Substance Use)
Cited by 0
Related Papers
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
|Drug and Alcohol Dependence|2020|119